Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska 68198-5800, USA.
J Proteome Res. 2011 Jul 1;10(7):3225-38. doi: 10.1021/pr200262q. Epub 2011 Jun 6.
Bridging conduits (BC) are tubular protrusions that facilitate cytoplasm and membrane exchanges between tethered cells. We now report that the human immunodeficiency virus type I (HIV-1) exploits these conduits to accelerate its spread and to shield it from immune surveillance. Endosome transport through BC drives HIV-1 intercellular transfers. How this occurs was studied in human monocyte-derived macrophages using proteomic, biochemical, and imaging techniques. Endosome, endoplasmic reticulum (ER), Golgi markers, and HIV-1 proteins were identified by proteomic assays in isolated conduits. Both the ER and Golgi showed elongated and tubular morphologies that extended into the conduits of polarized macrophages. Env and Gag antigen and fluorescent HIV-1 tracking demonstrated that these viral constituents were sequestered into endocytic and ER-Golgi organelles. Sequestered infectious viral components targeted the Golgi and ER by retrograde transport from early and Rab9 late endosomes. Disruption of the ER-Golgi network impaired HIV-1 trafficking in the conduit endosomes. This study provides, for the first time, mechanisms for how BC Golgi and ER direct cell-cell viral transfer.
桥接小体(BC)是管状突起,可促进连接细胞之间的细胞质和膜交换。我们现在报告,人类免疫缺陷病毒 I 型(HIV-1)利用这些小体来加速其传播并使其免受免疫监测。通过 BC 的内体运输驱动 HIV-1 细胞间转移。使用蛋白质组学、生化和成像技术,在人单核细胞衍生的巨噬细胞中研究了这种情况是如何发生的。通过蛋白质组学分析在分离的小体中鉴定了内体、内质网 (ER)、高尔基体标记物和 HIV-1 蛋白。ER 和高尔基体均显示出拉长和管状形态,延伸到极化巨噬细胞的小体中。Env 和 Gag 抗原和荧光 HIV-1 追踪表明,这些病毒成分被隔离到内体和 ER-Golgi 细胞器中。通过从早期和 Rab9 晚期内涵体的逆行运输,被隔离的感染性病毒成分靶向高尔基体和 ER。破坏 ER-Golgi 网络会损害小体内涵体中的 HIV-1 转运。这项研究首次提供了 BC 高尔基体和 ER 如何指导细胞间病毒转移的机制。